United States Vaccines Market 2015 - 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts

SKU ID : DPI- 12699823

Publishing Date : 23-Nov-2018

No. of pages : 115

PRICE
1390
2090


  • United States vaccines market is set to surpass US$ 21 Billion threshold by 2025.

    “United States Vaccines Market 2015 - 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for United States vaccines market. The report includes historic data from 2015 to 2017 and forecasts until 2025.

    The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the United States vaccines market. The report also explores detailed analysis of top 21 vaccines market assessment in United States from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the vaccines pricing trends and regulatory landscape in United States.

    Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States vaccines market.

    The report concludes with the profiles of major players in the United States vaccines market. The key market players are evaluated on various parameters such as business overview, promising vaccines in the clinical development and recent development.

    The major companies dominating this market for its products, services and continuous product developments are:

    Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline(GSK)

    Top 21 Vaccines Covered Under This Report Are:

    • Prevnar/Prevnar 13
    • Gardasil/Gardasil 9
    • Fluzone
    • Varivax
    • Menactra
    • Proquad
    • Pneumovax
    • FluLaval/Fluarix
    • Havrix/Twinrix/Engerix-B
    • MMR II
    • Adacel
    • Boostrix
    • Bexsero
    • Menveo
    • Trumenba
    • Shingrix
    • Pentacel
    • Recombivax HB
    • Rotateq
    • Rotarix
    • Pediarix/Infanrix

    The Latest Industry Data Included in this Report:

    • United States Vaccines Market Size & Analysis (2015 - 2025)
    • United States Vaccines Market Share & Y-o-Y Growth (%), 2015 – 2025
    • United States Top 21 Vaccines Market Assessment & Opportunity (2015 – 2025)
    • United States Vaccines Pricing Trends & Analysis
    • United States Vaccines Regulatory System
    • Major Deals in United States Vaccines Market
    • Promising Vaccines in Clinical Development by Major Companies
    • Key Market Drivers and Inhibitors of the United States Vaccines Market
    • Major Companies Analysis


    The answers to the following key questions can be found in the report:

    • What is the size of the United States vaccines market during 2015 -2025?
    • What will be the revenue generated by each vaccine during the forecast period?
    • Which major vaccine provides highest market share?
    • How are the overall market and vaccine type growing?
    • What are the key drivers and inhibitors in the current market? What will be the
    impact of drivers and inhibitors in the future?
    • What are the various vaccines available in the United States?
    • How is the market predicted to develop in the future?
    • Who are the key players in this market space?